全球深层脑部刺激器市场规模（依产品类型、应用、最终用户、区域范围和预测）

深层脑部刺激器市场规模及预测

深层脑部刺激器市场规模预计在 2023 年达到 14.6 亿美元，到 2032 年将达到 27.7 亿美元，2026 年至 2032 年的复合年增长率为 9.20%。

深层脑部刺激器(DBS) 是医疗设备。这些设备与脉衝发生器相连，通常植入于胸部皮下。 DBS 通常用于控制异常脑部活动，可有效治疗多种神经系统疾病。

肌张力不全症刺激 (DBS) 常用于治疗神经系统疾病，尤其是帕金森氏症和肌张力不全症。对于帕金森氏症，DBS 可减轻震颤、僵硬和心搏过缓等运动症状，显着改善患者的生活品质。对于肌张力失调，DBS 可抑制不自主肌肉收缩，进而达到运动控制。 DBS 也正在被研究用于强迫性精神官能症(OCD)、癫痫和重度忧郁症疾病，这进一步增强了其治疗潜力。

深层脑部刺激器(DBS) 的未来应用或将扩展至治疗更广泛的神经和精神疾病，包括癫痫、重度忧郁症和强迫性精神官能症(OCD)。目前，相关研究正在不断完善刺激技术，并开发能够即时回应脑部活动的自适应 DBS 系统，以增强治疗效果。此外，神经影像学和个人化医疗的进步有望实现客製化的刺激通讯协定，从而改善患者预后并减少传统 DBS 疗法相关的副作用。

全球深层脑部刺激器市场动态

影响全球深层脑部刺激器市场的关键市场动态是：

关键市场驱动因素

神经系统疾病盛行率不断上升：帕金森氏症、癫痫和肌张力不全症等神经系统疾病盛行率不断上升，推动了对深部脑电刺激 (DBS) 设备的需求。随着人口老化，这些疾病的盛行率预计将上升，从而增加对有效替代疗法的需求。 DBS 已被证明有助于缓解症状并改善患者的生活质量，从而扩大了市场。

技术进步：深部脑电刺激 (DBS) 技术的创新，包括更复杂设备和更精细刺激方法的开发，正在提高治疗的有效性和安全性。能够根据脑活动即时调整刺激的自适应 DBS 设备的开发是一项重要成就。此类技术正在改善患者预后，同时最大限度地减少不良反应，使 DBS 成为患者和医护人员更理想的治疗选择。

深部脑电刺激 (DBS) 疗法的认知度和接受度不断提升：医疗保健专业人员和患者对 DBS 疗法益处的认知度不断提升，推动了市场扩张。相关教育计画和宣传活动使人们更了解治疗过程，从而提高了接受度。随着越来越多的患者寻求药物治疗的替代方案，尤其是在治疗手段有限的患者中，对 DBS 设备的需求不断增长，从而推动了市场成长。

主要问题

治疗费用高昂：DBS 治疗的主要挑战之一是高昂的费用。许多患者不仅无力负担设备购买费用，还可能无法负担手术植入和后续治疗费用。这一巨大的经济障碍通常会限制 DBS 的治疗，尤其是在医疗资源有限的新兴国家。 DBS 的保险覆盖范围各不相同，患者可能难以获得报销，从而限制了他们获得治疗的机会。

监管障碍：深部脑电刺激 (DBS) 设备的监管审批流程漫长而复杂。製造商必须遵循严格的规定，并进行全面的临床测试以证明其安全性和有效性，这可能会导致产品上市延迟并增加开发成本。此外，各国监管规范的差异也进一步加剧了复杂性，使企业难以在国际市场上销售产品。

临床限制和风险：儘管已证实深部脑电刺激 (DBS) 对某些疾病有效，但由于合适患者数量不足以及手术可能存在的风险，其应用受到限制。并非所有患者对 DBS 反应良好，部分患者可能会出现感染、设备故障和神经系统问题等副作用。这些临床局限性可能会阻碍患者和医疗保健专业人员将 DBS 作为治疗选择，从而影响市场成长。

主要趋势

技术进步：最显着的趋势之一是深部脑部电刺激 (DBS) 技术的快速发展。能够根据即时脑活动调整刺激的闭合迴路系统正变得越来越普遍。这些设备透过根据患者的独特需求提供精准的电脉衝来优化治疗，从而有可能改善疗效并最大限度地减少副作用。此外，电极设计和材料的进步也提高了深部脑电刺激 (DBS) 设备的有效性和耐用性。

用途不断拓展：另一个关键进展是DBS的应用范围不断扩展，超越了典型的使用案例。虽然DBS主要用于治疗帕金森氏症和肌张力不全症，但研究人员也在探索其治疗一系列神经和精神疾病的潜力，包括强迫性精神官能症(OCD)和重度忧郁症。这种应用范围的广泛性正在推动需求，并为市场成长创造新的机会。

认知度与接受度的提升：随着人们对深部脑电刺激（DBS）作为潜在治疗方案的认知度不断提升，市场成长也日益显着。教育活动和倡导团体正在大力宣传DBS的益处，从而提升了医疗专业人士和患者的接受度。卓越的临床疗效和患者口碑也印证了这一趋势，增强了人们对DBS作为一种安全有效治疗方法各种疾病的信心。

目录

第一章 全球深层脑部刺激器市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 全球深层脑部刺激器市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球深层脑部刺激器市场（依产品类型）

• 概述
• 单通道深层脑部刺激器
• 双通道深层脑部刺激器

第六章 全球深层脑部刺激器市场（依应用）

• 概述
• 帕金森氏症
• 自发性震颤
• 肌张力不全症
• 癫痫
• 其他的

第七章 全球深层脑部刺激器市场（按最终用户）

• 概述
• 医院
• 门诊手术中心
• 神经科诊所
• 其他的

第八章全球深层脑部刺激器市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章全球深层脑部刺激器市场竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• Boston Scientific Corporation
• Medtronic Plc
• Abbott Laboratories
• NeuroPace Inc
• Renishaw Plc
• Beijing PINS Medical Co. Ltd
• LivaNova PLC
• Nexstim
• Aleva Neurotherapeutics
• St. Jude Medical

第十一章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十二章 附录

• 相关调查

Deep Brain Stimulation Devices Market Size And Forecast

Deep Brain Stimulation Devices Market size was valued at USD 1.46 Billion in 2023 and is projected to reach USD 2.77 Billion by 2032, growing at a CAGR of 9.20% from 2026 to 2032.

Deep Brain Stimulation Devices (DBS) are medical devices that send electrical impulses to specific brain regions via implanted electrodes. These devices are linked to a pulse generator which is normally inserted beneath the skin in the chest region. DBS is generally used to control aberrant brain activity which has therapeutic benefits for a variety of neurological diseases.

They are generally used to treat neurological illnesses, specifically Parkinson's disease and dystonia. In Parkinson's disease, DBS reduces motor symptoms such as tremors, stiffness, and bradykinesia, considerably increasing patients' quality of life. DBS can aid with dystonia by reducing involuntary muscle contractions allowing for more movement control. DBS is also being investigated for illnesses such as obsessive-compulsive disorder (OCD), epilepsy, and major depressive disorder, which increases its therapeutic potential.

The future uses of Deep Brain Stimulation Devices (DBS) may expand to treat a wider range of neurological and psychiatric disorders such as epilepsy, major depressive disorder, and obsessive-compulsive disorder (OCD). Research is ongoing to refine stimulation techniques and develop adaptive DBS systems that respond in real-time to brain activity enhancing treatment efficacy. Additionally, advancements in neuroimaging and personalized medicine could enable tailored stimulation protocols improving outcomes for patients and reducing side effects associated with traditional DBS therapies.

Global Deep Brain Stimulation Devices Market Dynamics

The key market dynamics that are shaping the global Deep Brain Stimulation Devices Market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological diseases such as Parkinson's disease, epilepsy, and dystonia has fuelled demand for DBS devices. As populations age, the prevalence of these illnesses is predicted to rise, creating a higher demand for effective treatment alternatives. DBS has been shown helpful in treating symptoms and enhancing patients' quality of life, resulting in market expansion.

Technological Advancements: DBS technology innovations, such as the creation of more complex devices and refined stimulation procedures, are improving the treatment's effectiveness and safety. The development of adaptive DBS devices that can modify stimulation in real-time based on brain activity is a significant achievement. These technologies increase patient results while minimising negative effects, making DBS a more desirable option for both patients and healthcare providers.

Growing Awareness and Acceptance of DBS Therapy: Increased awareness among healthcare professionals and patients about the benefits of DBS therapy helps to drive market expansion. Educational programs and advocacy efforts are helping to demystify the treatment process, resulting in more acceptance. As more patients seek alternatives to medication, particularly when treatment is limited, demand for DBS devices rises, promoting market growth.

Key Challenges:

High Cost of Treatment: One of the main challenges is the high expense of DBS therapy. Many patients may be unable to afford the gadgets as well as surgical installation and continuing follow-up care. This significant financial barrier frequently restricts access to DBS, especially in developing countries where healthcare resources are limited. Insurance coverage for DBS varies, and patients may have difficulty receiving reimbursement restricting treatment access.

Regulatory Hurdles: The regulatory licensing process for DBS devices can be lengthy and complicated. Manufacturers must follow strict rules and conduct thorough clinical trials to demonstrate safety and efficacy. This might lead to delayed product introductions and higher development expenditures. Furthermore, various regulatory norms across countries add another layer of complexity making it difficult for companies to market their products internationally

Clinical Limitations and Risks: While DBS has shown beneficial for some illnesses, its use is limited because of a lack of appropriate patients and the possible hazards involved with surgery. Not all patients respond well to DBS, and some may develop side effects including infection, device malfunction, or neurological problems. These clinical constraints may dissuade patients and healthcare professionals from using DBS as a therapeutic option affecting market growth.

Key Trends:

Technological Advancements: One of the most noteworthy trends is the rapid development of DBS technology. Closed-loop systems which adapt stimulation to real-time brain activity, are becoming more common. These devices can optimize treatment by delivering precise electrical impulses suited to the patient's specific needs, potentially boosting outcomes while minimising negative effects. Furthermore, advances in electrode design and materials improve the efficacy and durability of DBS devices.

Increasing Applications: Another key development is the growth of DBS applications beyond their typical use cases. While DBS has predominantly been used to treat Parkinson's disease and dystonia, researchers are also investigating its potential for treating various neurological and psychiatric diseases such as epilepsy, obsessive-compulsive disorder (OCD), and major depressive disorder. This expanded breadth is increasing demand and creating new opportunities for market growth.

Growing Awareness and Acceptance: Increased knowledge of DBS as a potential treatment option is also driving market growth. Educational activities and advocacy groups are publicising the benefits of DBS, resulting in increased acceptability among healthcare professionals and patients. This trend is supported by excellent clinical outcomes and patient testimonials that promote faith in DBS as a safe and effective treatment for a variety of disorders

Global Deep Brain Stimulation Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Deep Brain Stimulation Devices Market:

North America:

North America dominates the deep brain stimulation (DBS) devices market due to its advanced healthcare infrastructure and strong expenditure in R&D. The presence of significant medical equipment manufacturers and cutting-edge technological advancements helps to accelerate the development of sophisticated DBS systems. Furthermore, the region has a strong regulatory structure that facilitates the approval and commercialization of medical devices enabling the availability of high-quality treatment choices for individuals with neurological illnesses.

Furthermore, the rising prevalence of disorders including Parkinson's disease, epilepsy, and depression in North America increases demand for DBS therapy. Growing awareness among healthcare professionals and patients about the usefulness of DBS in controlling various illnesses helps to drive market expansion. Collaboration among healthcare providers, researchers, and manufacturers creates a favorable climate for clinical trials and product introductions reinforcing North America's dominant position in the worldwide DBS device industry.

Asia-Pacific:

Asia Pacific is the fastest-growing region in the deep brain stimulation (DBS) devices market, owing to several factors including the rising prevalence of neurological illnesses such as Parkinson's disease, epilepsy, and depression. As the population ages, the prevalence of these disorders rises generating the need for effective treatments such as DBS. Furthermore, improved healthcare infrastructure in countries such as China and India increases access to innovative medical technologies which drives market growth.

Furthermore, the region is seeing tremendous investment in R&D, which is driving advancements in DBS technology. Governments and the commercial sector are working to promote neuromodulation medicines which are critical to improving patient outcomes. Increased awareness of DBS among healthcare professionals and patients combined with favorable reimbursement regulations is also helping to drive the market in Asia Pacific. This combination of increased demand, technological developments, and supporting healthcare regulations places Asia Pacific as a market leader for DBS devices.

Global Deep Brain Stimulation Devices Market: Segmentation Analysis

The Deep Brain Stimulation Devices Market is segmented based on Product Type, Application, End-User, and Geography.

Deep Brain Stimulation Devices Market, By Product Type

• Single-channel Deep Brain Stimulator
• Dual-channel Deep Brain Stimulator

Based on the Product Type, the Global Deep Brain Stimulation Devices Market is bifurcated into Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator. The dual-channel deep brain stimulator is more dominant in the Deep Brain Stimulation Devices Market. This dominance stems from its ability to target multiple brain regions simultaneously offering more effective treatment for complex neurological conditions. By allowing for independent programming of each channel, dual-channel stimulators enhance therapeutic outcomes and provide greater customization for patient needs. This versatility and improved efficacy make dual-channel devices the preferred choice among healthcare providers contributing to their increased market share over single-channel stimulators.

Deep Brain Stimulation Devices Market, By Application

• Parkinson's Disease
• Essential Tremor
• Dystonia
• Epilepsy
• Others

Based on Application, the Global Deep Brain Stimulation Devices Market is bifurcated into Parkinson's Disease, Essential Tremor, Dystonia, Epilepsy, and Others. In the Deep Brain Stimulation (DBS) Devices market, Parkinson's Disease is the most dominant indication. The significant prevalence of Parkinson's disease, along with its challenging motor symptoms such as tremors and rigidity, drives the demand for DBS as an effective treatment option. Additionally, the established efficacy of DBS in alleviating symptoms of Parkinson's enhances its adoption among healthcare providers. While other conditions like Essential Tremor and Dystonia also contribute to the market, Parkinson's remains the leading focus for DBS applications.

Deep Brain Stimulation Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Neurological Clinics
• Others

Based on the End-User, the Global Deep Brain Stimulation Devices Market is bifurcated into Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others. Hospitals are the most dominant segment in the Deep Brain Stimulation Devices Market. They offer comprehensive neurological care, including specialized surgical procedures and post-operative support for patients undergoing deep brain stimulation. The presence of advanced medical facilities and experienced healthcare professionals in hospitals ensures proper device implantation and patient management. Additionally, hospitals are often involved in clinical trials and research contributing to advancements in DBS technology and treatment protocols which further solidifies their leading position in the market.

Deep Brain Stimulation Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Deep Brain Stimulation Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is more dominant in the deep brain stimulation (DBS) devices market due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of neurological disorders such as Parkinson's disease and epilepsy. The presence of key market players and innovative technologies in the region fosters rapid advancements in DBS solutions. Additionally, favorable reimbursement policies and increasing awareness of DBS therapies among healthcare professionals and patients contribute to the growing adoption of these devices in North America.

Key Players

The "Global Deep Brain Stimulation Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, LivaNova PLC, Aleva NeuroTechnologies, Beijing PINS Medical Co., Ltd, SceneRay Co Ltd., and Michigan Tech Researchers.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Deep Brain Stimulation Devices Market Key Developments

• In June 2020, Percept, a deep brain stimulation device from Medtronic, was approved by the FDA. Brain Sense technology is used by the company to continuously capture, record, and monitor brain signals in individuals with neurological diseases. It has the potential to aid clinicians in tracking patient brain activity and enhancing data-driven, tailored neurostimulation treatment.
• In 2021, Abbott, received FDA approval for its new rechargeable deep brain stimulation system, the Liberta RC, which is noted for being the smallest and having the longest battery life among DBS devices. This innovation aims to enhance patient comfort and convenience by reducing the frequency of recharges.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Single-channel Deep Brain Stimulator
• 5.3 Dual-channel Deep Brain Stimulator

6 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET., BY APPLICATION

• 6.1 Overview
• 6.2 Parkinson's Disease
• 6.3 Essential Tremor
• 6.4 Dystonia
• 6.5 Epilepsy
• 6.6 Others

7 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Neurological Clinics
• 7.5 Others

8 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Medtronic Plc
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Abbott Laboratories
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 NeuroPace Inc
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Renishaw Plc
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Beijing PINS Medical Co. Ltd
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 LivaNova PLC
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Nexstim
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Aleva Neurotherapeutics
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 St. Jude Medical
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research